CD133, a widely-accepted Cancer Stem Cell (CSC) marker [12,13,14], was also shown to be regulated through ets motifs as well as hypoxia-inducible elements, through the interaction of HIF-1α and Elk-1 on the promoter [15]. Here, ELK1 is linked to cancer.